• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTEGRAFT, INC. ARTEGRAFT; COLLAGEN VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTEGRAFT, INC. ARTEGRAFT; COLLAGEN VASCULAR GRAFT Back to Search Results
Model Number AG715
Device Problem Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/17/2015
Event Type  malfunction  
Manufacturer Narrative
Batch record review was performed; the batch met all criteria, including pressure testing, sterility testing, and final visual inspection upon release.The patient status was reported as stable.A previous capa ((b)(4)) was initiated for graft leakage.The complaint issue will continue to be monitored within artegraft, inc.Quality systems, quality assurance trending.Device was discarded by the physician.
 
Event Description
Artegraft inc.Received an email communication from an authorized distributor that an artegraft (collagen vascular graft) was identified as leaking and explanted.Upon follow-up communications with the physician, it was stated that the graft was pressure tested and flushed per the artegraft ifu.After tunneling the graft began "leaking" and was not able to be used "was never sewed in" (i.E.Anastomic connection).The physician reported that it appeared that there were multiple small leaks from the side walls of the graft.This primary graft was intended to be implanted in the patient's upper arm.As a result, an alternate ptfe graft was implanted and the patient is reported in stable condition.Some conflicting details were initially provided from the distributor such as the physician did not remember pressure testing prior to implanting but tested it after the graft was removed from the patient.It was stated that the physician stitched the venous end first and "filled it up" and saw "oozing".The artegraft was disposed of via medical waste at the hospital and the product was not available for artegraft review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTEGRAFT
Type of Device
COLLAGEN VASCULAR GRAFT
Manufacturer (Section D)
ARTEGRAFT, INC.
206 north center drive
north brunswick NJ 08902 4247
Manufacturer (Section G)
ARTEGRAFT, INC
206 north center drive
north brunswick NJ 08902 4247
Manufacturer Contact
cynthia salter
206 north center drive
north brunswick, NJ 08902-4247
7324228333
MDR Report Key5144139
MDR Text Key28044841
Report Number2247686-2015-00007
Device Sequence Number1
Product Code LXA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N16837
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Physician
Report Date 09/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date07/31/2017
Device Model NumberAG715
Device Catalogue NumberAG715
Device Lot Number14G186-013
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/17/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/08/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age85 YR
Patient Weight52
-
-